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Introduction 
Community-acquired pneumonia is a 
leading cause of morbidity and mortality 
with Mycoplasma pneumoniae (M. 
pneumoniae) accounting for up to 30% of all 
cases.1-3 M. pneumoniae usually presents 
with a benign course. Fewer than 10% of 
cases are clinically apparent and fewer than 
5% of those cases requiring hospitalization.3-
5 Of those requiring hospitalization, 10% 
will require admission to an intensive care 
unit (ICU) with mechanical ventilation as a 
result of Acute Respiratory Distress 
Syndrome (ARDS). 
The literature presents cases where a 
previously healthy subject, between the ages 
of 18 and 37, progressed to ARDS and the 
associated severe complications.4-8 Many of 
these cases presented for medical treatment 
after up to 10 days of non-specific 
symptoms such as fatigue, myalgia, and 
low- to high-grade fever. The majority of 
these cases received appropriate medical 
care, including antibiotic therapy, at time of 
presentation. However, disease progression 
continued and sometimes resulted in patient 
demise.  
Theories explaining how M. pneumoniae 
infection can require admission to an ICU 
for a young, previously healthy adult rely on 
the host’s immune response rather than the 
microbial agent.3,9,10 The immune response 
mounted by the host, a delayed hyper-
sensitivity   with   an   associated   excessive 
 
 
host-cellular response involving neutrophils, 
IL-2, IL-8, IL-12, IL-18, causes the damage 
to the lung parenchyma that results in 
ARDS. Due to this hypothesis, the addition 
of high dose corticosteroids in conjunction 
with the appropriate antibiotic coverage is 
successful in treating this subpopulation.3,4,8 
We present a case in which the 
appropriate antibiotic coverage was 
insufficient to prevent the progression of 
respiratory distress. After the patient was 
intubated and admitted to the ICU, 
corticosteroids were added to the treatment 
regimen and the patient made a complete 
recovery. 
 
Case Report 
A 46-year-old woman with a 19-month 
history of seizure disorder, secondary to a 
closed head injury, presented with altered 
mental status for the preceding 24 hours. 
Home medications included valproate, 
levetiracetam, hydrocodone/acetaminophen, 
propranolol, and alprazolam. Social history 
was significant for tobacco use and a 
monogamous long-term sexual relationship. 
Recent history included a flight to Atlanta 
one week earlier to visit a hospitalized and 
intubated relative diagnosed with AIDS and 
lymphoma.  
The patient arrived via emergency 
medical services (EMS) with a Glasgow 
Coma Scale (GCS) of 7 (Eyes 2, Verbal 2, 
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Motor 3). Associated signs and symptoms 
recorded by EMS included tachycardia (130 
bpm), hypotension (70/36 mmHg), difficulty 
in breathing, productive cough for past four 
days, decreased appetite and oral intake, 
hypoglycemia (31 mg/dL), and four break-
through seizures in the previous 24 hours. In 
the emergency department, the patient’s 
vitals stabilized initially. Her oxygen 
saturation (O2Sat) then decreased to 89% 
and subsequently to 79%, requiring BiPAP 
of 10 cmH2O/5 cmH2O with FiO2 of 1.00 to 
return to 100% O2Sat.  
On physical examination at time of 
admission, the patient was unresponsive 
with sluggish pupils constricted to 1 mm and 
bilateral crackles upon auscultation of the 
lungs. The patient was in shock and 
resuscitation was started. A chest x-ray was 
obtained (see Figure 1a).  
Laboratory testing revealed leukocytosis 
(20.6 x 103/mm3) with a predominance of 
neutrophils (86%). Other significant labor-
atory findings included elevated INR (1.39) 
elevated liver enzymes (AST 1045 U/L; 
ALT 569 U/L) and ammonia (164 µmol/L), 
and evidence of hemolysis (LDH 1344 U/L).   
Initial treatment included naloxone, 
dextrose, dexamethasone, and normal saline 
bolus with improvement in the patient’s 
mental status. Empiric treatment included 
trimethoprim/sulfamethoxazole, ceftriaxone, 
azithromycin, and nystatin. Samples were 
cultured and serology testing was 
performed. The results were negative for 
influenza A and B, Streptococcus pneu-
moniae, viral hepatitis A, B, and C, 
legionella, human immunodeficiency virus 
(HIV), cytomegalovirus (CMV), and 
Pneumocystis jirovecii (P. jirovecii). Only 
the serology tests for Mycoplasma IgM and 
IgG were positive.  
On the second day, respiratory distress 
progressed despite antibiotic treatment. The 
patient was intubated and transferred to ICU 
with oxygen saturation less than 80% and 
respiratory rate greater than 50. The chest x-
ray at this time is presented in Figure 1b.  
On the fifth day of admission, her 
clinical presentation had not improved and 
high dose corticosteroids were added to her 
regimen. The patient’s respiratory function 
improved and she was extubated on the 
seventh day of admission. The chest x-ray at 
this time is shown in Figure 1c.  
The patient was discharged the 
following day with prescriptions for 
azithromycin for three weeks and tapered 
prednisone for two weeks. She was 
scheduled for a follow-up appointment one 
week later. 
 
Discussion 
This case highlighted the need to be 
aware of M. pneumoniae as an agent capable 
of causing a serious clinical picture. The 
patient presented as a medical resuscitation 
and that made many conditions more likely 
candidates than M. pneumoniae on the initial 
differential diagnoses. Suspicions of other 
causative agents mirrored the approach of 
others in similar instances.6 Abnormal liver 
function tests initially were attributed to 
valproate use, but the values trended 
towards normal without discontinuation of 
valproate. Serum viral hepatitis titers also 
were negative suggesting the hepatitis was 
due most likely to the severe M. pneumoniae 
infection.3,6 Elevated lactate dehydrogenase 
(LDH) suggested P. jiroveci, but sputum 
testing was negative and the patient was 
confirmed to be HIV negative. Elevated 
LDH has been reported in other cases of M. 
pneumoniae progressing to respiratory 
failure.3 While elevated LDH and 
transaminase levels may be associated with 
severe M. pneumoniae infections, the 
contribution of multiple seizures and 
hemolytic anemia cannot be negated 
entirely. However, both of these clinical 
manifestations also were most likely the 
result of the M. pneumoniae infection.
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Figure 1.  Patient chest x-rays:  (a) At admission, diffuse bilateral ground glass opacities without focal consolidation; (b) On 2nd day, 
worsening diffuse bilateral ground glass opacities; (c) On 7th day, persistent left lower lobe patchy infiltrates with interval slight 
improvement in the left perihilar region and right lower lobe. 
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Currently, antimicrobials are the sole 
therapy for M. pneumoniae, but this case 
and those in the literature demonstrated they 
are not always sufficient to halt the disease 
progression and prevent the need for 
mechanical ventilation.4,6-8 Animal studies 
have shown that early treatment with 
corticosteroids and antibiotics is crucial in 
the successful resolution of symptoms and 
prevention of fulminant pneumonia and 
death.4,10  
Of the 13 cases of fatal M. pneumonia 
infection reviewed by Chan and Welsh,4 
only two patients may have received 
corticosteroids with antibiotic treatment.  
One patient received only one dose and it is 
questionable whether the second patient 
received corticosteroids at all. Interestingly, 
8 of 26 patients with non-fatal respiratory 
failure received combination therapy.4  
Other case studies reported this 
successful combination.11 Daxboeck et al.6 
presented a fatal case of respiratory failure 
due to M. pneumoniae in which the clinical 
deterioration progressed despite the 
“presumable eradication of the pathogen 
itself.” Chan and Welsh’s review4 noted four 
cases of “unusually severe” M. pneumoniae 
infection in immunocompromised adoles-
cents for which the chest x-ray demonstrated 
minimal or no changes. Furthermore, these 
same patients made a recovery with anti-
biotic treatment alone. For our immuno-
competent patient, the combination of 
antibiotics and corticosteroids led to 
improvements in her status when antibiotics 
alone did not halt the progressive respiratory 
failure. 
In retrospect, there were other factors to 
consider with this patient. The multiple 
seizures preceding hospitalization could 
have contributed to the ARDS. Aspiration of 
stomach contents during a seizure is not 
necessarily common but has been 
documented to occur.12 In our case, the 
sputum samples did not provide evidence of 
stomach flora and the chest x-ray did not 
show a focal consolidation. Chemical 
damage from aspiration was unlikely to be 
the cause of failure in our case, but should 
be a consideration in similar instances. 
The seizure activity was interesting. The 
patient reported compliance with her 
valproate regimen and the laboratory results 
supported the claim. Neurologic compli-
cations of M. pneumoniae infection include 
both central and nervous system involve-
ment4,8,13,14 and it is possible that our 
patient’s seizures were a manifestation of 
these complications.  
On autopsy of a previously healthy 27-
year-old woman who succumbed to ARDS 
secondary to M. pneumoniae infection, 
Tapyrik and Goldenberg8 noted acute 
hemorrhagic leukoencephalitis (AHLE). 
One of the fatal cases of respiratory failure 
reviewed by Chan and Welsh4 also 
demonstrated “multiple thrombi in lepto-
meninges” on autopsy and one of the non-
fatal cases was noted to have “Guillain-
Barre syndrome”. Seales and Greer13 
presented a case of AHLE that occurred 
approximately seven days after the onset of 
M. pneumoniae infection. Their patient 
made a complete recovery with treatment 
including corticosteroids.  
Our patient’s anemia was not unusual. 
M. pneumonia has caused cold agglutinins 
and anemia even in mild cases of 
pneumonia.15 While we did not have the 
data related to the patient’s hematologic 
status prior to this case, we have reason to 
believe that her anemia was of new onset 
and hemolytic in nature. The size and 
hemoglobin concentration of the patient’s 
red blood cells were within normal limits, 
but her LDH was elevated.  
The final consideration is the judicious 
use of corticosteroids despite the demon-
strated benefits with complications such as 
ARDS and AHLE.3,4,8,13 Time is of the 
essence with evidence to suggest that the 
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sooner corticosteroid treatment is initiated, 
the better the clinical outcome will be.3,4,8,10 
However, care must be taken to insure the 
appropriate antibiotic treatment continues as 
the immune response is suppressed to 
prevent further damage to the lungs and 
nervous system. This is of utmost 
importance for patients who are intubated 
for mechanical ventilation as they may be at 
an increased risk of acquiring a nosocomial 
infection.16 The index of suspicion should be 
high as there is evidence that identifying a 
nosocomial infection in an ICU patient is 
difficult at the best of times.17 
 
Conclusion 
M. pneumoniae  infection often does  not  
require hospitalization or antibiotic treat-
ment but our patient presented an example 
where hospitalization, ICU admission, and 
mechanical ventilation were all required. 
Antibiotic treatment alone was insufficient 
to halt the progression of the respiratory 
failure. Clinical improvement and resolution 
occurred in the setting of combination 
therapy with azithromycin and high-dose 
corticosteroids. 
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